Latest Press Releases

Health News Posted on Tuesday, March 4, 2025

Premium Press Releases »

Esaote Presents the New Portable Ultrasound System MyLab C30 at the European Congress of Radiology

VIENNA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- A newborn ultrasound series designed with a clear project in mind: ease-of-use, maximum portability and cleanability, together with the excellence in image quality. It is MyLabC-Series, the new portable ...

Read More

Philips Expands Cloud-based Enterprise Imaging Services to Europe for Better Access to AI-Enabled Workflows and Innovation

February 27, 2025 Accelerating cloud adoption across Europe with Philips HealthSuite Imaging cloud services on Amazon Web Services Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, ...

Read More

KFNCCC Welcomes Georgina Rodríguez's Visit to Support Young Cancer Patients

RIYADH, Saudi Arabia, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The King Fahad National Centre for Children’s Cancer (KFNCCC), a subsidiary of the King Faisal Specialist Hospital and Research Centre (KFSHRC), in collaboration with the Spanish ...

Read More

Press Releases »

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

PR Newswire JERSEY CITY, N.J., March 3, 2025 JERSEY CITY, N.J., March 3, 2025 /PRNewswire/ -- Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) and OSENVELT® (CT-P41, ...

Read More

Taiwan's First Hospital to Achieve AMAM Stage 7 Certification!

PR Newswire TAICHUNG, March 3, 2025 China Medical University Hospital Sets a New Benchmark in AI-Powered Smart Healthcare TAICHUNG, March 3, 2025 /PRNewswire/ -- China Medical University Hospital (CMUH) has once again achieved a major ...

Read More

CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of CS2009, a PD-1/VEGF/CTLA-4 Trispecific Antibody

PR Newswire SUZHOU, China, March 3, 2025 SUZHOU, China, March 3, 2025 /PRNewswire/ --CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer ...

Read More

Simple algorithm helps improve treatment, reduce disparities in MS

PR Newswire MINNEAPOLIS, March 3, 2025 MINNEAPOLIS, March 3, 2025 /PRNewswire/ -- A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study ...

Read More

Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia

PR Newswire MELBOURNE, Australia, March 3, 2025 Highlights: MELBOURNE, Australia, March 3, 2025 /PRNewswire/ -- Avecho Biotechnology Limited (ASX: AVE) ("Avecho" or the "Company") today announced it has signed an exclusive ten-year ...

Read More

Sleep apnea linked to increased risk of Parkinson's, but CPAP may reduce risk

PR Newswire MINNEAPOLIS, March 3, 2025 Risk reduced if treatment started within two years of diagnosis MINNEAPOLIS, March 3, 2025 /PRNewswire/ -- People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if ...

Read More

Eko Health Announces New Study Demonstrating AI-Assisted Detection of Reduced Ejection Fraction

PR Newswire SAN FRANCISCO, March 3, 2025 Published in the Journal of the American College of Cardiology (JACC) Advances, the study highlights the potential of Eko's platform to aid in detecting reduced ejection fraction (EF), a key indicator ...

Read More

AMSURG Urges Early Screening Amid Rising Colon Cancer Rates During Awareness Month

PR Newswire NASHVILLE, Tenn., March 3, 2025 NASHVILLE, Tenn., March 3, 2025 /PRNewswire/ -- As Colon Cancer Awareness Month kicks off, AMSURG, a national leader in ambulatory surgery center services and gastrointestinal (GI) care, is ...

Read More

MedStar Health Finds 79% of People Polled are Unaware of when to get a Colonoscopy

PR Newswire COLUMBIA, Md., March 3, 2025 National survey conducted in recognition of Colorectal Cancer Month in March. COLUMBIA, Md., March 3, 2025 /PRNewswire/ -- A national survey conducted by MedStar Health to gauge the public's ...

Read More

New research spotlights global and Canadian perceptions of menopause and the impact of enduring stigma on women's mental health, healthcare and careers

Canada NewsWire MARKHAM, ON, March 3, 2025 MARKHAM, ON, March 3, 2025 /CNW/ - Astellas Pharma Canada Inc. is pleased to share new findings from the Menopause Experience & Attitudes Study (MEAS), an international study examining societal ...

Read More

Latigo Biotherapeutics Granted FDA Fast Track Designation for LTG-001, Potential Best-in-Class Nav1.8 Inhibitor for the Non-Opioid Treatment of Acute Pain

PR Newswire THOUSAND OAKS, Calif., March 3, 2025 LTG-001 demonstrated favorable safety and tolerability profile with predictable pharmacokinetics in Phase 1 trial Fast Track designation will facilitate development and expedited ...

Read More

QALSODY™ (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause

Canada NewsWire TORONTO, March 3, 2025 TORONTO, March 3, 2025 /CNW/ - Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance with Conditions (NOC/c)) for QALSODY™ ...

Read More

Manipal Hospitals Hosts 'The Living Threads' Human Library Event at Bengaluru

PR Newswire BENGALURU, India, March 3, 2025 BENGALURU, India, March 3, 2025 /PRNewswire/ -- With the launch of 'The Living Threads' Human Library Event, Manipal Hospitals brought a fresh, thought-provoking initiative to life on Saturday, 22 ...

Read More

Obesity Care Week 2025 Challenges Everyone to "Commit to Care"

PR Newswire TAMPA, Fla., March 3, 2025 TAMPA, Fla., March 3, 2025 /PRNewswire/ -- Obesity Care Week (OCW) returns for its annual global campaign aimed at raising awareness, educating and advocating for individuals affected by obesity. This ...

Read More

AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity

PR Newswire NORTH CHICAGO, Ill. and HØRSHOLM, Denmark, March 3, 2025 NORTH CHICAGO, Ill. and HØRSHOLM, Denmark, March 3, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Gubra A/S (CPSE:GUBRA), a company specializing in preclinical contract ...

Read More

MARCH IS 'POP MONTH' CELEBRATING PROSTHETISTS, ORTHOTISTS & PEDORTHISTS WHO ENHANCE QUALITY OF LIFE FOR MILLIONS OF PEOPLE

PR Newswire ALEXANDRIA, Va., March 3, 2025 Dozens of national organizations to commemorate "POP Month" Activities will celebrate the achievements of POP professionals and their impact on society while building awareness of this ...

Read More

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2a-bias Bispecific Antibody Fusion Protein) in Melanoma

PR Newswire SAN FRANCISCO and SUZHOU, China, March 2, 2025 SAN FRANCISCO and SUZHOU, China, March 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...

Read More

POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

PR Newswire THOUSAND OAKS, Calif., March 1, 2025 Significantly Reduced Nasal Congestion, Polyp Size and Nearly Eliminated Need for Surgery Data Published in NEJM and Presented at AAAAI/WAO 2025 THOUSAND OAKS, Calif., March 1, 2025 ...

Read More

Sucraid® (sacrosidase) Oral Solution. Free 4-Day Trial Now Available. The only FDA- approved therapy to treat CSID (Congenital Sucrase-Isomaltase Deficiency)

PR Newswire VERO BEACH, Fla., March 1, 2025 VERO BEACH, Fla., March 1, 2025 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced Sucraid® (sacrosidase) Oral Solution has been shown to be 81% ...

Read More

Thousands Across the U.S. To Go Bald and Take Action for Childhood Cancer Research This Month

PR Newswire LOS ANGELES, March 1, 2025 March marks more than 25 years of shaving heads to Conquer Kids' Cancer LOS ANGELES, March 1, 2025 /PRNewswire/ -- This March, communities across the U.S. will come together to support the St. ...

Read More

Women of Global Change Malaysia: Pioneering Education, Health, and Empowerment for a Brighter Future

PR Newswire KUALA LUMPUR, Malaysia, Feb. 28, 2025 The Women of Global Change Malaysia chapter, led by Chapter President Anne Tham, is dedicated to empowering communities through education, healthcare initiatives, and sustainable projects. By ...

Read More

Supporting community-led responses to the illegal toxic drug and overdose crisis

Canada NewsWire THUNDER BAY, ON, Feb. 28, 2025 Funding will prioritize urgent needs at community level THUNDER BAY, ON, Feb. 28, 2025 /CNW/ - No community has been left untouched by the toxic drug and overdose crisis. Its tragic impacts ...

Read More

Increasing supports for residents of Northwest Territories to quit smoking

Canada NewsWire YELLOWKNIFE, NT, Feb. 28, 2025 YELLOWKNIFE, NT, Feb. 28, 2025 /CNW/ - Tobacco use remains a significant preventable cause of premature death in Canada, with approximately 46,000 people dying from tobacco-related illnesses ...

Read More

Gov. DeSantis announces $2 million to expand access to FIU personalized cancer treatment technology

PR Newswire MIAMI, Feb. 28, 2025 MIAMI, Feb. 28, 2025 /PRNewswire/ -- Gov. Ron DeSantis on Friday announced $2 million in funding from the Casey DeSantis Florida Cancer Innovation Fund, to increase patients' access to FIU cancer researcher ...

Read More

Supporting a community-led response to the illegal toxic drug and overdose crisis in Northwestern Ontario

Canada NewsWire THUNDER BAY, ON, Feb. 28, 2025 THUNDER BAY, ON, Feb. 28, 2025 /CNW/ - The illegal toxic drug supply and overdose crisis is having tragic impacts on communities throughout Canada. Our family, friends and neighbours have been ...

Read More

Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration

PR Newswire HAYWARD, Calif., Feb. 28, 2025 HAYWARD, Calif., Feb. 28, 2025 /PRNewswire/ -- Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the commencement of Investigational New Drug ...

Read More

BNCT Market Booms with 38.7% CAGR - A Game-Changer in Cancer Treatment | Valuates Reports

PR Newswire BANGALORE, India, Feb. 28, 2025 Boron Neutron Capture Therapy (BNCT) Market is Segmented by Type (Thermal Beam, Epithermal Beam), by Application (Brain Tumor, Extracranial Tumor). BANGALORE, India, Feb. 28, 2025 /PRNewswire/ ...

Read More

Memorial Regional Hospital South Pioneers Voice-Activated Smart Control Solution for Patients with Spinal Injuries

PR Newswire HOLLYWOOD, Fla., Feb. 28, 2025 Memorial Rehabilitation Institute is the first in the U.S. to implement Hatchmed SmartHub powered by Aiva HOLLYWOOD, Fla., Feb. 28, 2025 /PRNewswire-PRWeb/ -- For individuals recovering from a ...

Read More

Disposable Gloves Market Size to Reach a Value of US$17.66 Billion by 2031, The Insight Partners

PR Newswire NEW YORK, Feb. 28, 2025 NEW YORK, Feb. 28, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the disposable gloves market share is expected to reach US$ 17.66 billion by 2031 from US$ 7.08 ...

Read More

Government of Canada takes further action to combat fentanyl production and organized crime

Canada NewsWire OTTAWA, ON, Feb. 28, 2025 OTTAWA, ON, Feb. 28, 2025 /CNW/ - The Minister of Mental Health and Addictions and Associate Minister of Health, Minister of Public Safety, and the Fentanyl Czar today announced new measures to ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.